J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yadav, V
Right arrow Articles by Sharma, G L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yadav, V
Right arrow Articles by Sharma, G L
Agricola
Right arrow Articles by Yadav, V
Right arrow Articles by Sharma, G L
J Med Microbiol 54 (2005), 375-379; DOI: 10.1099/jmm.0.45748-0
© 2005 Society for General Microbiology
ISSN 0022-2615

A fraction from Escherichia coli with anti-Aspergillus properties

V Yadav1, R Mandhan2, Rajesh Dabur3, A K Chhillar1, J Gupta1 and G L Sharma1,3

1Institute of Genomics and Integrative Biology, Mall Road, Delhi University Campus, Delhi, India 2Department of Biotechnology, Kurukshetra University, Kurukshetra, India 3Department of Biomedical Sciences, Bundelkhund University, Jhansi, India

Correspondence G. L. Sharma drglsharma{at}hotmail.com

Received May 18, 2004
Accepted December 2, 2004

The products of various strains of Escherichia coli (BL21, DH5{alpha}, HB101 and XL Blue) were investigated for antimycotic properties using pathogenic isolates of Aspergillus. Co-culture experiments revealed that E. coli strains exhibited variable activity against Aspergillus fumigatus. The lysates prepared from DH5{alpha}, HB101 and XL Blue strains of E. coli showed inhibitory activity against A. fumigatus in the protein concentration range of 62.50 to 250.00 µg ml–1. The highest activity was seen in the lysate of BL21, which inhibited the growth of A. fumigatus and Aspergillus flavus completely at a concentration of 31.25 µg protein ml–1. The MIC of BL21 lysate against Aspergillus niger was found to be 62.50 µg ml–1. The in vitro toxicity of BL21 lysate was evaluated using a haemolytic assay. A BL21 lysate protein concentration of 1250.00 µg ml–1 was found to be nontoxic to human erythrocytes. The standard drug amphotericin B lysed 100 % of erythrocytes at a concentration of 37.50 µg ml–1. SDS-PAGE showed the presence of at least 15 major proteins in the lysate of BL21. Ion-exchange chromatography resolved the BL21 lysate into five fractions and fraction III was found to be endowed with anti-Aspergillus properties. The MIC of this fraction was found to be 3.90 µg ml–1. Further work on the purification of the active molecule and its characterization is in progress.




This article has been cited by other articles:


Home page
 J Med MicrobiolHome page
V. Yadav, R. Mandhan, Q. Pasha, S. Pasha, A. Katyal, A. K. Chhillar, J. Gupta, R. Dabur, and G. L. Sharma
An antifungal protein from Escherichia coli
J. Med. Microbiol., May 1, 2007; 56(5): 637 - 644.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2005 Society for General Microbiology.